FINCH THERAPEUTICS GROUP INC - COM (FNCH)

CUSIP: 31773D101

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
9,861,883
Share change
-690,886
Total reported value
$28,007,000
Price per share
$2.84
Number of holders
40
Value change
-$3,695,799
Number of buys
17
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 31773D101?
CUSIP 31773D101 identifies FNCH - FINCH THERAPEUTICS GROUP INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FINCH THERAPEUTICS GROUP INC - COM (FNCH) as of Q2 2022

As of 30 Jun 2022, FINCH THERAPEUTICS GROUP INC - COM (FNCH) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,861,883 shares. The largest 10 holders included SUSQUEHANNA INTERNATIONAL GROUP, LLP, Avenir Management Company, LLC, BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, Bleichroeder LP, LAKE STREET ADVISORS GROUP, LLC, TRB Advisors LP, MSD Partners, L.P., Ikarian Capital, LLC, and Oasis Management Co Ltd.. This page lists 40 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.